Kristen K. Buck - Sep 1, 2021 Form 4 Insider Report for CALADRIUS BIOSCIENCES, INC. (LSTA)

Role: EVP, R&D and CMO
Signature: Kristen K. Buck, by Todd Girolamo, Esq., Attorney-in-Fact
Stock symbol: LSTA
Transactions as of: Sep 1, 2021
Transactions value $: -$64,132
Form type: 4
Date filed: 9/3/2021, 04:04 PM
Next filing: Jan 12, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LSTA	Common Stock	Award	$0	+313K		$0.00	313K	Sep 1, 2021	Direct	F1
transaction	LSTA	Common Stock	Tax liability	-$64.1K	-50.1K	-16.03%	$1.28	262K	Sep 1, 2021	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LSTA	Stock Option (Right to Buy)	Award	$0	+1.14M		$0.00	1.14M	Sep 1, 2021	Common Stock	1.14M	$1.28	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents 312,500 restricted stock awards granted under the Issuer's 2018 Equity Incentive Compensation Plan. The restricted stock awards vest in three equal installments, with one-third of the shares vesting on the date of grant and an additional one-third vesting on each of the first and second annual anniversaries of the grant date.
F2	Includes 209,375 unvested restricted stock awards.
F3	One-third of the shares underlying the stock options vest immediately on the grant date, with an additional one-third vesting on each of the first and second annual anniversaries of the grant date.